Exploring the Physical Form Landscape of Clozapine, Amoxapine and Loxapine

• Accelrys (2010) Pipeline pilot in chemistry collection: basic chemistry user guide. Accelrys Inc., 5005 Wateridge Vista Drive, San Diego, CA 92121

  Google Scholar

• Ashby CJ, Wang R (1996) Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24:349–394

  Article CAS Google Scholar

• Bastin RJ, Bowker MJ, Slater BJ (2000) Salt selection and optimisation procedures for pharmaceutical new chemical entities. Org Process Res Dev 4:427–435

  Article CAS Google Scholar

• Bhardwaj RM, Price LS, Price SL, Reutzel-Edens SM, Miller GJ, Oswald IDH, Johnston BF, Florence AJ (2013) Exploring the experimental and computed crystal energy landscape of olanzapine. Cryst Growth Des 13:1602–1617

  Article CAS Google Scholar

• Boultif A, Louer D (1991) Indexing of powder diffraction patterns for low-symmetry lattices by the successive dichotomy method. J Appl Crystallogr 24:987–993

  Article CAS Google Scholar

• Braun DE, Karamertzanis PG, Arlin J-B, Florence AJ, Kahlenberg V, Tocher DA, Griesser UJ, Price SL (2010) Solid-state forms of β-resorcylic acid: How exhaustive should a polymorph screen be? Cryst Growth Des 11:210–220

  Article Google Scholar

• Capuano B, Crosby IT, Gable RW, Lloyd EJ (2000) N-Piperonyl analogue of the atypical antipsychotic clozapine. Acta Crystallogr C 56:339–340

  Article Google Scholar

• Capuano B, Crosby IT, Egan SJ, Fallon GD, Lloyd EJ, Neve JE (2005) 4-Chloro-N-[4-(8-chloro-5H-dibenzo[b, e][1,4]diazepin-11-yl)-1-methylpiperazinio]benzamidate dichloromethane solvate. Acta Crystallogr Sect E 61:o20–o22

  Article CAS Google Scholar

• Capuano B, Crosby I, Forsyth C, McRobb F, Moudretski V, Taylor D, Vom A, Yuriev E (2010) New hybrids of clozapine and haloperidol and their isosteric analogues: synthesis, X-ray crystallography, conformational analysis and preliminary pharmacological evaluation. Struct Chem 21:613–628

  Article CAS Google Scholar

• Clark SJ, Segall MD, Pickard CJ, Hasnip PJ, Probert MJ, Refson K, Payne MC (2005) First principles methods using CASTEP. Zeitschrift Fur Kristallographie 220:567–570

  CAS Google Scholar

• Coelho A (2003) Indexing of powder diffraction patterns by iterative use of singular value decomposition. J Appl Crystallogr 36:86–95

  Article CAS Google Scholar

• Cosulich DB, Lovell FM (1977) The X-ray crystal structures of loxapine 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b, f][1,4]oxazepine and amoxapine {2-chloro-11-(1-piperazinyl)dibenz[b, f][1,4]oxazepine}. Acta Crystallogr B 33:1147–1154

  Article Google Scholar

• Desiraju GR (1991) The C-H.cntdot.cntdot.cntdot.O hydrogen bond in crystals: What is it? Acc Chem Res 24:290–296

  Article CAS Google Scholar

• Desiraju GR (2002) Hydrogen bridges in crystal engineering: interactions without borders. Acc Chem Res 35:565–573

  Article CAS Google Scholar

• Dunitz JD, Gavezzotti A (2005) Toward a quantitative description of crystal packing in terms of molecular pairs: application to the hexamorphic crystal system, 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile. Cryst Growth Des 5:2180–2189

  Article CAS Google Scholar

• Dupont L, Liegeois J-F (2003) 8-chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzoxazepine. Acta Crystallogr Sect E 59:o1962–o1963

  Article CAS Google Scholar

• Dupont L, Liegeois J-F, Rogister F, Delarge J (1996) 8-chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzodiazepine. Acta Crystallogr Sect C 52:391–393

  Article Google Scholar

• Fillers JP, Hawkinson SW (1982a) The structure of 4-(2-chlorodibenz[b, f][1,4]oxazepin-11-yl)-1-methyl-1H-piperazinium succinate monohydrate (loxapine succinate monohydrate). Acta Crystallogr Sect B 38:3041–3045

  Article Google Scholar

• Fillers JP, Hawkinson SW (1982b) The structure of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b, e][1,4]diazepine dihydrobromide, clozapine dihydrobromide. Acta Crystallogr Sect B 38:1750–1753

  Article Google Scholar

• Florence AJ, Shankland N, Shankland K, David WIF, Pidcock E, Xu X, Johnston A, Kennedy AR, Cox PJ, Evans JSO, Steele G, Cosgrove SD, Frampton CS (2005) Solving molecular crystal structures from laboratory X-ray powder diffraction data with DASH: the state of the art and challenges. J Appl Crystallogr 38:249–259

  Article CAS Google Scholar

• Florence AJ, Johnston A, Price SL, Nowell H, Kennedy AR, Shankland N (2006) An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine. J Pharm Sci 95:1918–1930

  Article CAS Google Scholar

• Florence AJ, Bedford CT, Fabbiani FPA, Shankland K, Gelbrich T, Hursthouse MB, Shankland N, Johnston A, Fernandes P (2008) Two-dimensional similarity between forms I and II of cytenamide, a carbamazepine analogue. CrystEngComm 10:811–813

  Article CAS Google Scholar

• Florence AJ, Bardin J, Johnston B, Shankland N, Griffin TAN, Shankland K (2009) Structure determination from powder data: Mogul and CASTEP. Zeitschrift Fur Kristallographie 215–220

  Google Scholar

• Frank A (2002) The cambridge structural database: a quarter of a million crystal structures and rising. Acta Crystallogr Sect B 58:380–388

  Article Google Scholar

• Greenbla E, Osterber A (1968) Pharmacodynamic actions of 2-chloro-11-(1-piperazinyl)dibenz [b, f] 1,4 oxazepine: a new psychoactive agent. Fed Proc 27:438

  Google Scholar

• Holden JR, Du Z, Ammon HL (1993) Prediction of possible crystal structures for C-, H-, N-, O-, and F- containing organic compounds. J Comput Chem 14:422–437

  Article CAS Google Scholar

• Jablensky A, Sartorius N, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1987) Incidence worldwide of schizophrenia. Br J Psychiatry 151:408–409

  CAS Google Scholar

• Kazantsev AV, Karamertzanis PG, Adjiman CS, Pantelides CC (2011a) Efficient handling of molecular flexibility in lattice energy minimization of organic crystals. J Chem Theor Comput 7:1998–2016

  Article CAS Google Scholar

• Kazantsev AV, Karamertzanis PG, Adjiman CS, Pantelides CC, Price SL, Galek PTA, Day GM, Cruz-Cabeza AJ (2011b) Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction. Int J Pharm 418:168–178

  Article CAS Google Scholar

• Kazantsev AV, Karamertzanis PG, Pantelides CC, Adjiman CS (2011c) Crystaloptimizer: an efficient algorithm for lattice energy minimization of organic crystals using isolated-molecule quantum mechanical calculations. Process Systems Engineering, Wiley-VCH Verlag GmbH & Co. KGaA, Germany, pp 1–42

  Google Scholar

• Latimer CN (1969) Neuropharmacologic evaluation of oxilapine a potent psychoactive agent. J Pharmacol Exp Ther 166:151–162

  CAS Google Scholar

• McKinnon JJ, Spackman MA, Mitchell AS (2004) Novel tools for visualizing and exploring intermolecular interactions in molecular crystals. Acta Crystallogr Sect B 60:627–668

  Article Google Scholar

• MOE (2002) Chemical computing group, 1010 Sherbrooke St. W, Montreal, Quebec, H3A 2R7. Qubec, Canada

  Google Scholar

• Petcher TJ, Weber H-P (1976) Conformations of some semi-rigid neuroleptic drugs. Part 1. Crystal structures of loxapine, clozapine, and HUF-2046 monohydrate {2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b, f][1,4]oxazepine, 8-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b, e][1,4]diazepine, and 2-chloro-11(4-methylpiperazin-1-yl)dibenzo[b, e][1,4]diazepine monohydrate}. J Chem Soc Perkin Trans 2:1415–1420

  Article Google Scholar

• Price SL, Leslie M, Welch GWA, Habgood M, Price LS, Karamertzanis PG, Day GM (2010) Modelling organic crystal structures using distributed multipole and polarizability-based model intermolecular potentials. Phys Chem Chem Phys 12:8478–8490

  Article CAS Google Scholar

• SIMCA (2012) Multivariate analysis software, version 13.0.0.0., Umetrics Ltd. MKS Instruments UK Ltd., Unit 3–4, Cowley Way, Weston Road, Crewe, Cheshire, CW1 6AG, UK

  Google Scholar

• Siva Lakshmi D, Prasunamba PL, Ravikumar KBS (2011) Solid state characterization of clozapine monohydrate. Struct Chem Commun 2:101–104

  Google Scholar

Download references